SNY logo

Sanofi (SNY) EBIT

annual EBIT:

$8.67B+$212.28M(+2.51%)
December 31, 2024

Summary

  • As of today (May 25, 2025), SNY annual earnings before interest & taxes is $8.67 billion, with the most recent change of +$212.28 million (+2.51%) on December 31, 2024.
  • During the last 3 years, SNY annual EBIT has fallen by -$1.02 billion (-10.50%).
  • SNY annual EBIT is now -46.58% below its all-time high of $16.23 billion, reached on December 31, 2020.

Performance

SNY EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

quarterly EBIT:

$2.49B+$2.12B(+561.15%)
March 31, 2025

Summary

  • As of today (May 25, 2025), SNY quarterly earnings before interest & taxes is $2.49 billion, with the most recent change of +$2.12 billion (+561.15%) on March 31, 2025.
  • Over the past year, SNY quarterly EBIT has increased by +$992.63 million (+66.08%).
  • SNY quarterly EBIT is now -76.54% below its all-time high of $10.64 billion, reached on March 31, 2008.

Performance

SNY quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

TTM EBIT:

$8.89B+$992.63M(+12.56%)
March 31, 2025

Summary

  • As of today (May 25, 2025), SNY TTM earnings before interest & taxes is $8.89 billion, with the most recent change of +$992.63 million (+12.56%) on March 31, 2025.
  • Over the past year, SNY TTM EBIT has increased by +$2.71 billion (+43.90%).
  • SNY TTM EBIT is now -33.80% below its all-time high of $13.44 billion, reached on June 30, 2020.

Performance

SNY TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

SNY EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.5%+66.1%+43.9%
3 y3 years-10.5%-7.6%-10.1%
5 y5 years+140.7%+9.3%+110.1%

SNY EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.5%+2.5%-39.8%+331.4%-28.4%+49.4%
5 y5-year-46.6%+140.7%-72.0%+331.4%-33.8%+110.1%
alltimeall time-46.6%+738.4%-76.5%+111.5%-33.8%+249.8%

SNY EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.49B(+561.2%)
$8.89B(+12.6%)
Dec 2024
$8.67B(+2.5%)
$377.35M(-90.9%)
$7.90B(+22.6%)
Sep 2024
-
$4.14B(+120.7%)
$6.45B(+8.3%)
Jun 2024
-
$1.88B(+25.0%)
$5.95B(-3.7%)
Mar 2024
-
$1.50B(-239.4%)
$6.18B(-17.6%)
Dec 2023
$8.46B(-26.3%)
-$1.08B(-129.5%)
$7.50B(-39.7%)
Sep 2023
-
$3.65B(+73.5%)
$12.42B(+7.4%)
Jun 2023
-
$2.10B(-25.3%)
$11.57B(+5.0%)
Mar 2023
-
$2.82B(-26.8%)
$11.01B(+1.1%)
Dec 2022
$11.48B(+18.5%)
$3.85B(+37.6%)
$10.90B(+23.9%)
Sep 2022
-
$2.80B(+80.3%)
$8.80B(-8.2%)
Jun 2022
-
$1.55B(-42.6%)
$9.58B(-3.2%)
Mar 2022
-
$2.70B(+54.5%)
$9.90B(+2.1%)
Dec 2021
$9.69B(-40.3%)
$1.75B(-51.1%)
$9.69B(+22.0%)
Sep 2021
-
$3.58B(+91.3%)
$7.94B(+81.9%)
Jun 2021
-
$1.87B(-25.1%)
$4.37B(-61.7%)
Mar 2021
-
$2.50B(-72.0%)
$11.41B(-15.1%)
Dec 2020
$16.23B(+350.7%)
-
-
Jun 2020
-
$8.92B(+290.5%)
$13.44B(+217.4%)
Mar 2020
-
$2.28B(-1474.6%)
$4.23B(+17.3%)
Dec 2019
$3.60B(-37.8%)
-$166.10M(-106.9%)
$3.61B(-1.5%)
Sep 2019
-
$2.40B(-938.8%)
$3.67B(-17.6%)
Jun 2019
-
-$286.47M(-117.3%)
$4.45B(-24.4%)
Mar 2019
-
$1.66B(-1599.6%)
$5.88B(+1.1%)
Dec 2018
$5.79B(-14.1%)
-$110.67M(-103.5%)
$5.82B(-15.0%)
Sep 2018
-
$3.18B(+177.5%)
$6.84B(+13.8%)
Jun 2018
-
$1.15B(-28.0%)
$6.01B(-6.6%)
Mar 2018
-
$1.59B(+74.5%)
$6.43B(-4.0%)
Dec 2017
$6.74B(-7.7%)
$913.81M(-61.2%)
$6.70B(-10.2%)
Sep 2017
-
$2.36B(+50.2%)
$7.46B(-4.3%)
Jun 2017
-
$1.57B(-15.8%)
$7.79B(-1.2%)
Mar 2017
-
$1.86B(+11.4%)
$7.89B(+7.9%)
Dec 2016
$7.30B(+13.4%)
$1.67B(-37.7%)
$7.31B(+21.0%)
Sep 2016
-
$2.69B(+61.4%)
$6.04B(+8.8%)
Jun 2016
-
$1.67B(+29.5%)
$5.55B(-8.3%)
Mar 2016
-
$1.29B(+218.6%)
$6.05B(-3.5%)
Dec 2015
$6.44B(-22.6%)
$403.73M(-81.6%)
$6.27B(-20.6%)
Sep 2015
-
$2.20B(+1.5%)
$7.90B(-2.3%)
Jun 2015
-
$2.16B(+43.6%)
$8.09B(+5.0%)
Mar 2015
-
$1.51B(-25.8%)
$7.70B(-7.2%)
Dec 2014
$8.32B(+23.0%)
$2.03B(-14.8%)
$8.30B(+3.9%)
Sep 2014
-
$2.38B(+34.0%)
$7.99B(+2.5%)
Jun 2014
-
$1.78B(-15.4%)
$7.79B(+12.5%)
Mar 2014
-
$2.10B(+22.0%)
$6.93B(+2.2%)
Dec 2013
$6.76B
$1.72B(-21.2%)
$6.77B(+21.1%)
Sep 2013
-
$2.19B(+138.7%)
$5.59B(-9.5%)
Jun 2013
-
$915.61M(-53.1%)
$6.18B(-16.1%)
DateAnnualQuarterlyTTM
Mar 2013
-
$1.95B(+260.7%)
$7.37B(-11.9%)
Dec 2012
$8.39B(+0.2%)
$540.92M(-80.5%)
$8.37B(-10.4%)
Sep 2012
-
$2.78B(+32.1%)
$9.34B(-5.7%)
Jun 2012
-
$2.10B(-28.8%)
$9.91B(+5.0%)
Mar 2012
-
$2.95B(+94.6%)
$9.44B(+12.7%)
Dec 2011
$8.37B(-4.9%)
$1.52B(-54.7%)
$8.38B(+4.4%)
Sep 2011
-
$3.34B(+105.6%)
$8.02B(+16.7%)
Jun 2011
-
$1.63B(-13.9%)
$6.88B(-16.3%)
Mar 2011
-
$1.89B(+62.4%)
$8.22B(-10.3%)
Dec 2010
$8.80B(-1.2%)
$1.16B(-47.1%)
$9.16B(-7.8%)
Sep 2010
-
$2.20B(-25.9%)
$9.93B(-3.1%)
Jun 2010
-
$2.97B(+4.8%)
$10.25B(+13.7%)
Mar 2010
-
$2.83B(+46.3%)
$9.02B(+1.8%)
Dec 2009
$8.91B(+35.0%)
$1.94B(-23.1%)
$8.86B(+182.7%)
Sep 2009
-
$2.52B(+45.2%)
$3.13B(-30.9%)
Jun 2009
-
$1.73B(-35.1%)
$4.54B(-14.1%)
Mar 2009
-
$2.67B(-170.5%)
$5.28B(-60.1%)
Dec 2008
$6.60B(-21.1%)
-$3.79B(-196.7%)
$13.24B(-382.6%)
Sep 2008
-
$3.92B(+58.0%)
-$4.69B(-578.0%)
Jun 2008
-
$2.48B(-76.7%)
$980.43M(+31.6%)
Mar 2008
-
$10.64B(-149.0%)
$744.95M(-215.7%)
Dec 2007
$8.36B(+10.9%)
-$21.72B(-326.6%)
-$643.73M(-316.8%)
Sep 2007
-
$9.59B(+327.0%)
$296.96M(+249.9%)
Jun 2007
-
$2.25B(-75.7%)
$84.87M(-110.8%)
Mar 2007
-
$9.25B(-144.5%)
-$783.24M(-86.8%)
Dec 2006
$7.54B(+6.0%)
-$20.78B(-321.7%)
-$5.94B(-158.4%)
Sep 2006
-
$9.37B(+580.8%)
$10.16B(+97.2%)
Jun 2006
-
$1.38B(-66.4%)
$5.15B(-7.4%)
Mar 2006
-
$4.09B(-187.5%)
$5.56B(-17.3%)
Dec 2005
$7.12B(+60.0%)
-$4.68B(-207.3%)
$6.73B(+95.2%)
Sep 2005
-
$4.36B(+144.1%)
$3.45B(-38.5%)
Jun 2005
-
$1.79B(-66.0%)
$5.61B(+18.3%)
Mar 2005
-
$5.26B(-166.0%)
$4.74B(+109.6%)
Dec 2004
$4.45B(+28.0%)
-$7.96B(-222.1%)
$2.26B(-64.8%)
Sep 2004
-
$6.52B(+608.2%)
$6.42B(+145.2%)
Jun 2004
-
$921.24M(-66.9%)
$2.62B(+5.3%)
Mar 2004
-
$2.78B(-173.1%)
$2.49B(+38.7%)
Dec 2003
$3.48B(+40.4%)
-$3.81B(-239.9%)
$1.79B(-32.1%)
Sep 2003
-
$2.72B(+244.4%)
$2.64B(+50.0%)
Jun 2003
-
$789.90M(-62.2%)
$1.76B(+14.5%)
Mar 2003
-
$2.09B(-170.6%)
$1.54B(-379.6%)
Dec 2002
$2.48B(+31.2%)
-$2.96B(-260.7%)
-$549.94M(-122.9%)
Sep 2002
-
$1.84B(+224.9%)
$2.41B(+324.9%)
Jun 2002
-
$566.21M
$566.21M
Dec 2001
$1.89B(+29.5%)
-
-
Dec 2000
$1.46B(+40.9%)
-
-
Dec 1999
$1.03B
-
-

FAQ

  • What is Sanofi annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Sanofi?
  • What is Sanofi annual EBIT year-on-year change?
  • What is Sanofi quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Sanofi?
  • What is Sanofi quarterly EBIT year-on-year change?
  • What is Sanofi TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Sanofi?
  • What is Sanofi TTM EBIT year-on-year change?

What is Sanofi annual earnings before interest & taxes?

The current annual EBIT of SNY is $8.67B

What is the all time high annual EBIT for Sanofi?

Sanofi all-time high annual earnings before interest & taxes is $16.23B

What is Sanofi annual EBIT year-on-year change?

Over the past year, SNY annual earnings before interest & taxes has changed by +$212.28M (+2.51%)

What is Sanofi quarterly earnings before interest & taxes?

The current quarterly EBIT of SNY is $2.49B

What is the all time high quarterly EBIT for Sanofi?

Sanofi all-time high quarterly earnings before interest & taxes is $10.64B

What is Sanofi quarterly EBIT year-on-year change?

Over the past year, SNY quarterly earnings before interest & taxes has changed by +$992.63M (+66.08%)

What is Sanofi TTM earnings before interest & taxes?

The current TTM EBIT of SNY is $8.89B

What is the all time high TTM EBIT for Sanofi?

Sanofi all-time high TTM earnings before interest & taxes is $13.44B

What is Sanofi TTM EBIT year-on-year change?

Over the past year, SNY TTM earnings before interest & taxes has changed by +$2.71B (+43.90%)
On this page